All publications and patent applications mentioned in this specification are herein incorporated by reference in their entirety to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
Described herein are imaging devices and systems for use in biological probes. In particular, described herein are catheter-based imaging systems using Optical Coherence Tomography (OCT) having a molded lens adapted to minimize parasitic back-reflections and provide superior distance imaging and beam diameter characteristics.
A number of vascular diseases, such as coronary artery disease and peripheral vascular disease, are caused by the build-up of atherosclerotic deposits (plaque) in the arteries, which limit blood flow to the tissues that are supplied by that particular artery. Disorders caused by occluded body vessels, including coronary artery disease (CAD) and peripheral artery disease (PAD), may be debilitating and life-threatening. Chronic Total Occlusion (CTO) can result in limb gangrene, requiring amputation, and may lead to other complications and eventually death. Increasingly, treatment of such blockages may include interventional procedures in which a guidewire is inserted through a catheter into the diseased artery and threaded to the blocked region. There the blockage may be either expanded into a more open position, for example, by pressure from an inflated catheter balloon (e.g., balloon angioplasty) and/or the blocked region may be held open by a stent. Treatment of such blockages can also include using a catheter to surgically remove the plaque from the inside of the artery (e.g., an atherectomy).
There is medical interest in equipping catheters with sensors that can help direct the catheter for atherectomy, occlusion-crossing, and/or other surgical procedures. For example, it would be useful to have sensors that can give the surgeon immediate visual feedback as to whether a particular tissue is diseased and/or how far away the cutting portion of a catheter is from the boundary of a particular blood vessel layer to minimize the risk of accidental damage. Conventional radiological imaging methods and ultrasound imaging systems have been attempted for such surgical procedures. However, neither ultrasound nor radiological imaging methods have enough resolution to help guide the operation of the catheter through small dimensions. Moreover, standard radiological techniques cannot easily discriminate between healthy tissue and diseased tissue unless the tissue has become heavily calcified. Further, the components of an ultrasound system are generally too large to implement on a small scale, such as with a system configured to be used within blood vessels.
Optical Coherence Tomography (OCT) has been proposed as one technique that may be particularly helpful for imaging regions of tissue, including within a body lumen such as a blood vessel. At a basic level, OCT relies on the fact that light traveling from a source and scattering from more distant objects takes longer to travel back than light scattering from nearby objects. Due to the wave nature of light, very small timing differences caused by light signals traveling different distances on the micron scale can cause constructive or destructive interference with reference light signals. OCT systems measure the resulting interference to obtain an image of the target. A typical OCT system requires one or more interferometers to distinguish the signal from the applied light. In addition, most known OCT systems, when applied to catheters, include a fiber that is rotated (often at high rates) within the catheter in order to scan the lumen and a second, large reference arm.
A typical OCT device includes a target arm and a reference arm to generate a reference signal. In order to provide the interference reference signal, the OCT device will split an illuminating light signal from the source in two equal or unequal parts, send part of the illuminating light to the target of interest through one target optical “target arm” and send the other part of the illuminating light down a separate reference arm. Light from the separate reference arm reflects off of a mirror, and then returns and interferes with the scattered light that is returning from the target optical arm after bouncing off of the target. In a traditional OCT device, the reference arm length is engineered to be exactly the same length as the target arm so that the interference effect is maximized. The resulting interference between the two beams creates interference that can be measured to extract depth information related to the target. Using this depth information, an image of the object can be generated. A typical OCT device can further include a focusing lens in the target arm, such as a graded index (GRIN) lens, configured to focus the light coming out of the optical fiber into the tissue.
These traditional OCT systems, however, are large and cumbersome due to the required reference arm and are therefore generally ineffective for use in a medical catheter, particularly for use with a low cost and disposable catheter. Using a common path OCT system, i.e., a system without a separate reference arm, is one way to eliminate the cost and size of such an imaging catheter. There are several challenges, however, associated with developing a catheter having common path OCT. For example, a common path OCT system requires that the reference reflection be formed within the same optical conduit as the target reflection. This reference reflection must be finely tuned to avoid noise in the system, requiring that the path from the light source to the reflection interface be free of unnecessary components, such as focusing elements that could interfere with the reference reflection. Further, the common path system must have components that are small enough to fit inside of a single small catheter, making it difficult to include additional components. Finally, for common path OCT, it is desirable to have the reference reflection as close to the tissue as possible to maintain the imaging range within the coherence length of the source and avoid data processing burden, as data processed for the distance between the reference and the start of the imaging is not useful. Accordingly, a common path OCT system that solves some of these problems is desired.
The distal imaging tip of a common-path OCT catheter should perform two main functions: (1) direct the beam towards the imaging object and (2) focus the beam on the imaging object for improved image quality. In addition, for common path OCT, the geometry and properties of the distal imaging assembly should be such that it introduces only one primary source of back-reflection (reference reflection) and avoid any other parasitic reflection which could causes artifacts in the images.
One way to address these needs that has been proposed (see, e.g., US-2015-0099984) which uses a common-path OCT system with a graded index (GRIN) fiber attached to the distal tip of a single mode optical fiber in the catheter so as to act as a lens for focusing light. Unfortunately, this solution has proven problematic. For example, the addition of any lens (e.g., a graded index (GRIN) lens) is difficult and results in potential failure modes.
Further, the manufacturing processes required to make these SMF-GRIN assemblies, such as that in device 100, is often difficult and requires precision alignment. Moreover, in order to splice the GRIN fiber 103 in front of the SMF fiber 110, the SMF fiber must be stripped to certain length (see stripped section 105 in
Moreover, focusing length may be sacrificed by using a GRIN fiber 103 and separate mirror 101. The focusing capability of the GRIN fiber 103 is a function of the diameter of the fiber. Using 125 micron GRIN fiber 103, to match the diameter of the SMF 110, the focus point is limited to 1-1.5 mm from the tip of the fiber. In imaging catheters where the fiber is deployed in the middle of the catheter, significant portion of the Rayleigh range of the beam could be lying inside the catheter. This reduces the imaging depth within which the imaging catheter is able to maintain high resolution.
Described herein are apparatuses, including tip assemblies for OCT (common path) imaging systems, and methods of making an using them, that may address the issues raised above.
In general, described herein are OCT apparatuses (including devices and systems) that include a lens assembly that is, or is capable of being, positioned at distal tip of an optical fiber to provide common-path OCT imaging. The lens assembly is typically an anamorphic lens assembly.
In some embodiments, the anamorphic lens assembly has a lens body, and a first surface coupled to the optical fiber through which light from the optical fiber may pass into the lens body so that it can be reflected from a second, reflective, surface at an angle, to direct light out of the lens assembly and into a tissue (e.g., at a 45 degree angle). The second, reflective, surface may have a compound radius so that the beam profile of the light beam from the optical fiber is made approximately circular as it exits the lens assembly (e.g., out of a third, flat, surface that is perpendicular to the direction of the beam) reflected from the second surface).
In other embodiments, the anamorphic lens assembly has a concave proximal surface that is reflective and includes a compound surface to reflect light therefrom.
The lens assemblies described herein may be used as part of a catheter capable of OCT imaging. For example, a catheter for optical coherence tomography (OCT) may include: an elongate catheter body extending distally to proximally, an optical fiber in the elongate catheter body, and a lens assembly optically coupled with a distal end of the optical fiber, the lens assembly, wherein the optical fiber and the lens assembly are together configured to provide a common path for optical radiation reflected from a target and from a reference interface between the distal end of the optical fiber and the first surface.
As mentioned, the lens assembly may be an anamorphic lens assembly, refractive or reflective, e.g., having non-uniform or different magnifications or radii of curvatures along the two axes perpendicular to each other (e.g., the axis perpendicular to the path of light traveling through the lens body). In some variations, the anamorphic lens may refer specifically to the compound radii of curvature of the mirror portion. In other variations, the anamorphic lens may refer to a mirror having continuously changing or different radii of curvature between the two perpendicular axes.
In any of the variations described herein, the lens assembly (e.g., the first surface of the lens assembly) may be connected to the distal end of the optical fiber by a layer of epoxy.
In general, some embodiments, the first surface (the surface immediately opposite the distal end of the optical fiber) may be at an angle relative to the distal end (out of which the light passes) of between about 2 degrees and 40 degrees relative to the distal end of the optical fiber, e.g., the angle may be between about 5 degrees and 13 degrees, between about 2 degrees and 20 degrees, between 6 degrees and 10 degrees, about 8 degrees, etc.). Further, the second (reflective, or mirrored) surface is angled relative to the distal end of the optical fiber, so that light traveling to/from the distal end of the optical fiber, after passing the first surface of the lens body, is reflected by the second surface and directed laterally out of the lens. For example, the second surface may be at an angle of between about 10 degrees and about 60 degrees (e.g., 20 degrees and 50 degrees, 30 degrees and 50 degrees, 40 degrees and 50 degrees, about 45 degrees, etc.) relative to the distal end of the optical fiber.
In some embodiments, the reflective proximal surface can be angled relative to the distal end of the optical fiber, so that light traveling to/from the distal end of the optical fiber and impinging on the proximal surface is reflected and directed laterally out of the lens. For example, the proximal surface may be at an angle of between about 10 degrees and about 60 degrees (e.g., 20 degrees and 50 degrees, 30 degrees and 50 degrees, 40 degrees and 50 degrees, about 45 degrees, etc.) relative to the distal end of the optical fiber
The reflective second surface may be formed by coating (and/or attaching) a reflective material to the outer face of the second surface. The reflective material coating the second surface may be coated at a thickness that is configured to reflect more than 70% (e.g., more than 75%, more than 80%, more than 85%, more than 90%, more than 95%, etc.) of light. Any appropriate reflective material may be used. For example, the reflective material may comprise gold, silver, platinum, etc.
In general, the reflective surfaces may comprise a compound radius, e.g., a compound radius having a different radius in an x and a y axis. The compound radius may be configured so that light (e.g., a beam of light) reflecting off of the second surface has a beam profile that is more circular when it exits the lens body than when it entered the lens body.
The lens (e.g., the lens body) may be formed of any material, particularly materials that may be molded. For example, the lens body may be formed of a polycarbonate material having a refractive index that is mismatched relative to the refractive index of the optical fiber. Thus, for example, a secondary reflection of optical radiation from an interface between the optical fiber and the lens assembly may be less than −60 dB. Further, the reference interface may provide a reference reflection of between about −28 and about −42 dB.
Any of the lens apparatuses, and/or any of the catheters including such lens apparatuses, described herein may be configured as a system including a light source and receiving electronics which may include a processor for generating OCT images. For example, a system for optical coherence tomography (OCT) may include: a source of optical radiation, an optical fiber extending distally to proximally, and a lens assembly optically coupled with a distal end of the optical fiber, wherein the optical fiber and the lens assembly are together configured to provide a common path for optical radiation reflected from a reference interface between the distal end of the optical fiber and the first surface, and from a target. The system can further include receiving electronics configured to receive the optical radiation reflected from the reference interface and the target and a processor to generate an image of the target based upon the optical radiation received by the receiving electronics.
Also described herein are method of takin OCT images including passing light from an optical fiber and into or off of a lens apparatus as described herein, The method can include creating minimal (e.g., less than −55 dB) secondary reflection results. The method may also include reflecting the light (beam) from the reflective surface at an angle of between about 30 degrees and 60 degrees (e.g., approximately 45 degrees) so that it projects laterally out of the device and into the tissue, then collecting light returning from the tissue and passing it back through the lens body and into the fiber optic, where it can be collected and processed (e.g., using a receiver and/or processor) to form an optical coherence tomographic image.
In general, in one embodiment, a catheter system for optical coherence tomography (OCT) includes an elongate catheter body extending distally to proximally, an optical fiber in the elongate catheter body, and a lens assembly optically coupled with a distal end of the optical fiber. The lens assembly includes a lens body having a first surface that is opposite from and at an angle relative to the distal end of the optical fiber and a second surface distal to the first surface. The second surface is coated with a reflective material so that light passing from the distal end of the optical fiber, through the first surface, and into the lens body reflects off of the second surface and out of the lens body. The optical fiber and the lens assembly are together configured to provide a common path for optical radiation reflected from a target and from a reference interface between the distal end of the optical fiber and the first surface.
In general, in one embodiment, a catheter system for optical coherence tomography (OCT) includes an elongate catheter body extending distally to proximally, an optical fiber in the elongate catheter body, and a lens assembly optically coupled with a distal end of the optical fiber. The lens assembly includes a lens body having a first surface that is opposite from and at an angle relative to the distal end of the optical fiber and a second surface distal to the first surface. The second surface has a compound radius having a first radius along a first axis that is different from a second radius along a second axis. That light passing from the distal end of the optical fiber, through the first surface, and into the lens body reflects off of the second surface and out of the lens body. The optical fiber and the lens assembly are together configured to provide a common path for optical radiation reflected from a target and from a reference interface between the distal end of the optical fiber and the first surface.
In general, in one embodiment, a catheter system for optical coherence tomography (OCT) includes an elongate catheter body extending distally to proximally, an optical fiber in the elongate catheter body, and a lens assembly having a first refractive index optically coupled with a distal end of the optical fiber by an interface medium. The interface medium has a second refractive index. The first refractive index and the second refractive index differ by 0.02 or less. The lens assembly includes a lens body having a first surface that is opposite from the distal end of the optical fiber and a second surface distal to the first surface. Light passing from the distal end of the optical fiber through the first surface and into the lens body reflects off of the second surface and out of the lens body. The optical fiber and the lens assembly are together configured to provide a common path for optical radiation reflected from a target and from a reference interface between the distal end of the optical fiber and the interface medium.
These and other embodiments can include one or more of the following features. The lens assembly can be an anamorphic lens assembly. The catheter system can further include an interface medium connecting the distal end of the optical fiber and the first surface. The interface medium can be an epoxy. The lens assembly can have a first refractive index and the interface medium can have a second refractive index, wherein the first refractive index and the second refractive index can differ by 0.02 or less. The first surface can be at an angle of 8 degrees or more relative to the distal end of the optical fiber. A tangent of the second surface can be at an angle of between about 40 degrees and 50 degrees relative to a longitudinal axis of the fiber. The catheter system can further include a reflective coating on the second surface. The reflective coating can have a thickness that is configured to reflect more than 80% of light. The reflective coating can be gold. The reflective material can be dielectric. The second surface can include a compound radius. The second surface can include a compound radius having a first radius along a first axis that is different than a second radius along a second axis. The lens body can include a polycarbonate material. A secondary reflection of optical radiation from an interface between the optical fiber and the lens assembly can be less than −60 dB. The reference interface can provide a reference reflection of between −28 and −42 dB. The second surface can be concave relative to the light passing from the distal end of the optical fiber. An exit surface of the lens assembly can be angled by 8 degrees or more relative to a central longitudinal axis of the optical fiber. The reflective coating can have an optical density of greater than or equal to 3.0. A radius of curvature of the second surface can be between 0.2 mm and 1.5 mm. The catheter system can further include a source of optical radiation configured to provide the light, and a reflective coating on the second surface can have a thickness of at least ⅙ of an excitation wavelength of the source of optical radiation. The catheter system can further include a source of optical radiation, receiving electronics configured to receive optical radiation reflected from the reference interface and the target, and a processor to generate an image of the target based upon the optical radiation received by the receiving electronics.
In general, in one embodiment, a catheter for optical coherence tomography (OCT) includes an elongate catheter body extending distally to proximally, an optical fiber in the elongate catheter body, and a lens assembly optically coupled with a distal end of the optical fiber by an interface medium. The lens assembly includes a lens body having a concave proximal surface that is opposite from and at an angle relative to the distal end of the optical fiber. The proximal surface has a compound radius having first radius along a first axis that is different from a second radius along a second axis. The proximal surface includes a reflective material configured to so that at least 90% light passing from the distal end of the optical fiber through the lens assembly reflects off of the proximal surface. The optical fiber and the lens assembly are together configured to provide a common path for optical radiation reflected from a target and from a reference interface between the distal end of the optical fiber and the proximal surface.
This and other embodiments can include one or more of the following features. The interface medium can be an epoxy. A tangent of the proximal surface can be at an angle of between about 40 degrees and 50 degrees relative to a longitudinal axis of the fiber. The reflective material can include a reflective coating on the proximal surface. The reflective coating can be gold. The reflective material can be dielectric. The lens body can include a polycarbonate material. A secondary reflection of optical radiation from an interface between the optical fiber and the lens assembly can be less than −60 dB. The reference interface can provide a reference reflection of between −28 and −42 dB. The reflective coating can have an optical density of greater than 3.0. A radius of curvature of the proximal surface can be between 0.2 mm and 1.5 mm. The catheter system can further include a source of optical radiation configured to provide the light, wherein a reflective coating on the proximal surface can have a thickness of at least ⅙ of an excitation wavelength of the source of optical radiation. The catheter system can further include a source of optical radiation, receiving electronics configured to receive optical radiation reflected from the reference interface and the target, and a processor to generate an image of the target based upon the optical radiation received by the receiving electronics.
In general, in one embodiment, a catheter for optical coherence tomography (OCT) includes an elongate catheter body extending distally to proximally, an optical fiber in the elongate catheter body, and a lens assembly optically coupled with a distal end of the optical fiber. The lens assembly includes a lens body having a first surface that is opposite from and at an angle relative to the distal end of the optical fiber and a second surface distal to the first surface. The second surface is uncoated such that light passing from the distal end of the optical fiber, through the first surface, and into the lens body reflects off of the second surface by total internal reflection and out of the lens body. The optical fiber and the lens assembly are together configured to provide a common path for optical radiation reflected from a target and from a reference interface between the distal end of the optical fiber and the first surface.
In general, in one embodiment, a catheter for optical coherence tomography (OCT) includes an elongate catheter body extending distally to proximally, an optical fiber in the elongate catheter body, and a lens assembly optically coupled with a distal end of the optical fiber by an interface medium. The lens assembly includes a lens body having a concave proximal surface that is opposite from and at an angle relative to the distal end of the optical fiber. The proximal surface has a compound radius having first radius along a first axis that is different from a second radius along a second axis. The proximal surface is uncoated such that light passing from the distal end of the optical fiber, through the first surface, and into the lens body reflects off of the second surface by total internal reflection and out of the lens body. The optical fiber and the lens assembly are together configured to provide a common path for optical radiation reflected from a target and from a reference interface between the distal end of the optical fiber and the proximal surface.
The novel features of the invention are set forth with particularity in the claims that follow. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:
Described herein are lens assemblies for use with an imaging device. Any of the lens assemblies described herein may be anamorphic lens assemblies (i.e., lens assemblies that are circularly nonsymmetric and have or produce unequal magnifications along two different axes, i.e., two different axes that are perpendicular to one another). The anamorphic lens, for example, can include two different radii along two different axes. The lens assemblies described herein may be used as part of any optical coherence tomography (OCT) device, and particularly as part of a common path OCT device, which may be included as part of a catheter or other device. The lens assembly may be, for example, placed in and/or on a distal tip of a catheter to: (1) direct the beam towards the imaging object and (2) focus the beam on the imaging object for improved image quality.
The lens assemblies described herein may be formed, e.g., using a mold. Thus, any of the lens assemblies may also be referred to as “molds” or “mold assemblies.” In some embodiments, the lens assemblies described herein may be made from polycarbonate material, such as Makrolon 2558. In some embodiments, the refractive index of the lens assembly can be close to the refractive index of the interface medium (e.g., epoxy) used to connect the lens assembly to the distal end of the imaging fiber optic.
Referring to
The distal surface 221 of the lens can have a compound radius (e.g., a different radius along the x-axis than along the y-axis). Further, the outer portion of the distal surface 221 can be convex (i.e., such that light hits the concave inner portion). The distal surface 221 can have a radius of curvature, for example, of between 0.2 mm and 1.5 mm.
Further, the distal surface 221 can include a mirror 201 attached or coated thereon. Thus, the mirror 201 can include a coating and/or attached layer on the distal surface 221 of the lens 210. The mirror can have a thickness that is configured to reflect more than 70% (e.g., more than 75%, more than 80%, more than 85%, more than 90%, more than 95%, etc.) of light. In one example, the mirror or coating can have a thickness of greater than or equal to 100 nm, such as greater than or equal to 200 nm or greater than or equal to 250 nm in thickness. In some embodiments, the mirror or coating can have an optical density of 3.0 or greater, such as 3.5 or greater. Any appropriate reflective material may be used for the mirror or coating. For example, the reflective material may include gold, silver, or platinum. Further, the mirror 201 can be angled at approximately 45 degrees, where the angle is defined as the angle off the intersection of the fiber optical axis the second surface (i.e., the angle between the optical axis and the tangent to the compound second surface at the intersection with the second surface).
In this embodiment, the proximal surface 211 of the lens 210 can be oriented substantially parallel to the distal surface 212 of the optical fiber. Further, the outer surface 217 of the lens 210 can be substantially parallel to the axis of the fiber 215 (and therefore substantially perpendicular to the proximal surface 211 of the lens and the distal surface 212 of the optical fiber). In one embodiment, surfaces 211, 217 can be substantially flat. In another embodiment, the surfaces can be slightly curved with a radius of curvature of 0.1 inches or more.
In use, light from the light source can pass through the optical fiber 215. At the interface of the distal end 212 of the optical fiber and the interface medium 202, some of the light will be reflected back so as to create the reference reflection. The rest of the light can pass from the distal end 212 of the optical fiber through the interface medium 202, and through the proximal surface 211 of the lens. Because the indices of refraction of the fiber and the interface medium are closely matched, only a minimal amount (e.g., less than −55 dB) of light will be reflected back from the surface 211. The light can thus travel through the lens 210 and impinge on the mirror 201. Because of the 45 degree angle and the compound surface of the mirror 201, the light can be reflected perpendicular to the longitudinal axis of the fiber 315 with a beam profile 213 that is close to circular when it exits the outer surface 217 of the lens 210.
As shown in
Referring to
Thus, as discussed above, the SMF-GRIN and mirror assembly required for many prior art devices can be replaced with a single anamorphic lens assembly as described herein.
In some embodiments, the anamorphic lenses described herein can be made of polycarbonate.
Further, in some embodiments, the lens assemblies described herein can be molded. Molding a material, such as a polycarbonate, can be relatively inexpensive and easy to make, simplifying the manufacturing process and lowering the cost for making imaging assemblies.
Referring to
The interface mediums described herein can be, for example, an epoxy, such as a UV-curing epoxy.
As mentioned and illustrated, the use of the anamorphic lens assemblies described herein may shorten the length of the distal tip of the devices in which the assemblies are used. The length of the stripped section of the fiber may be much smaller, so the distal imaging and therapeutic housing can be made much smaller.
The lens assemblies described herein can have significantly better focusing capability suited to the geometry of a catheter. For example, the radius of curvature of the anamorphic lens structures described herein may be such that the focus is a preferred (further) distance away from the housing.
In some embodiments, the lens assemblies described herein can themselves cause the reflection of the light beam into the tissue. That is, the reflective surfaces can be uncoated, and the reflection can be caused by a total internal reflection resulting from the mismatch of the refractive indices between the lens material and the interface medium and/or air surrounding the lens. In such embodiments, the refractive index of the lens material can be high, such as 1.0 or greater, 1.2 or greater, 1.5 or greater, or 1.7 or greater. Further, in embodiments where light travels through the lens, the distal surface of the lens can be bordered by air to ensure total internal reflection.
In some embodiments, the reference reflection can be made by a surface other than the optical fiber/interface medium surface. For example, the reference reflection can be made by the proximal or distal surfaces of the lens assembly and/or by the outer surface of the lens assembly. In such an embodiment, the indices of refraction of the interface medium and the core of the optical fiber can be closely matched (e.g., within 0.02) in order to provide only minimal secondary reflection at that interface.
The lens assemblies described herein can be used with a variety of different imaging catheters. For example, the lens assemblies can be used with: U.S. patent application Ser. No. 12/829,277, filed Jul. 1, 2010, titled “ATHERECTOMY CATHETER WITH LATERALLY-DISPLACEABLE TIP,” now U.S. Patent Application Publication No. 2011/0004107; U.S. patent application Ser. No. 12/829,267, filed Jul. 1, 2010, titled “CATHETER-BASED OFF-AXIS OPTICAL COHERENCE TOMOGRAPHY IMAGING SYSTEM,” now U.S. Pat. No. 9,125,562; U.S. patent application Ser. No. 13/175,232, filed Jul. 1, 2011, titled “ATHERECTOMY CATHETERS WITH LONGITUDINALLY DISPLACEABLE DRIVE SHAFTS,” now U.S. Pat. No. 9,345,510; U.S. patent application Ser. No. 13/433,049, filed Mar. 28, 2012, titled “OCCLUSION-CROSSING DEVICES, IMAGING, AND ATHERECTOMY DEVICES,” now U.S. Pat. No. 8,644,913; U.S. patent application Ser. No. 14/401,175, filed Nov. 14, 2014, titled “ATHERECTOMY CATHETERS WITH IMAGING,” now U.S. Patent Application Publication No. 2016/0141816; U.S. patent application Ser. No. 14/424,277, filed Feb. 26, 2015, titled “BALLOON ATHERECTOMY CATHETERS WITH IMAGING,” now U.S. Patent Application Publication No. 2015/0208922; U.S. patent application Ser. No. 14/776,750, filed Sep. 15, 2015, titled “CHRONIC TOTAL OCCLUSION CROSSING DEVICES WITH IMAGING, now U.S. Patent Application Publication No. 2016/0029902; U.S. patent application Ser. No. 15/072,272, filed Mar. 16, 2016, titled “ATHERECTOMY CATHETERS DEVICES HAVING MULTI-CHANNEL BUSHINGS,” now U.S. Patent Application Publication No. 2016/0192962; U.S. patent application Ser. No. 15/076,568, filed Feb. 5, 2015, titled “ATHERECTOMY CATHETERS AND OCCLUSION CROSSING DEVICES;” and International Patent Application No. PCT/US2015/039585, filed Jul. 8, 2015, titled “HIGH SPEED CHRONIC TOTAL OCCLUSION CROSSING DEVICES,” now International Patent Publication No. WO 2016/007652, the entireties of which are incorporated by reference.
The lens assemblies described herein can be used, for example, as part of an optical coherence tomography (OCT) system. Referring to
In some embodiments, a secondary reflection of optical radiation from an interface between the optical fiber and the lens assembly is less than −60 dB. Further, in some embodiments, the reference interface provides a reference reflection of between −28 and −42 dB.
Also described herein are carbon dioxide supply cartridges that can be used, for example, to inflate a balloon of a balloon catheter.
The carbon dioxide supply devices 900, 1000 can be used with a variety of different balloon catheters. For example, the devices 900, 1000 can be used with balloon atherectomy catheters, such as those described in International Patent Application No. PCT/US2013/032494, filed Mar. 15, 2013, titled “BALOON ATHERECTOMY CATHETERS WITH IMAGING,” and International Patent Application No. PCT/US2015/014613, filed Feb. 5, 2015, titled “ATHERECTOMY CATHETERS AND OCCLUSION CROSSING DEVICES,” incorporated by reference herein in their entireties. The carbon dioxide supply device 100 can further be used, for example, with balloon angioplasty catheters. Advantageously, the carbon dioxide supply devices 900,1000 can be a single-use sterile product.
Although described as a carbon dioxide supply, other inflation gases can be used in devices 900, 1000.
When a feature or element is herein referred to as being “on” another feature or element, it can be directly on the other feature or element or intervening features and/or elements may also be present. In contrast, when a feature or element is referred to as being “directly on” another feature or element, there are no intervening features or elements present. It will also be understood that, when a feature or element is referred to as being “connected”, “attached” or “coupled” to another feature or element, it can be directly connected, attached or coupled to the other feature or element or intervening features or elements may be present. In contrast, when a feature or element is referred to as being “directly connected”, “directly attached” or “directly coupled” to another feature or element, there are no intervening features or elements present. Although described or shown with respect to one embodiment, the features and elements so described or shown can apply to other embodiments. It will also be appreciated by those of skill in the art that references to a structure or feature that is disposed “adjacent” another feature may have portions that overlap or underlie the adjacent feature.
Terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. For example, as used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprises” and/or “comprising,” when used in this specification, specify the presence of stated features, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, steps, operations, elements, components, and/or groups thereof. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items and may be abbreviated as “/”.
Spatially relative terms, such as “under”, “below”, “lower”, “over”, “upper” and the like, may be used herein for ease of description to describe one element or feature's relationship to another element(s) or feature(s) as illustrated in the figures. It will be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation in addition to the orientation depicted in the figures. For example, if a device in the figures is inverted, elements described as “under” or “beneath” other elements or features would then be oriented “over” the other elements or features. Thus, the exemplary term “under” can encompass both an orientation of over and under. The device may be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptors used herein interpreted accordingly. Similarly, the terms “upwardly”, “downwardly”, “vertical”, “horizontal” and the like are used herein for the purpose of explanation only unless specifically indicated otherwise.
Although the terms “first” and “second” may be used herein to describe various features/elements, these features/elements should not be limited by these terms, unless the context indicates otherwise. These terms may be used to distinguish one feature/element from another feature/element. Thus, a first feature/element discussed below could be termed a second feature/element, and similarly, a second feature/element discussed below could be termed a first feature/element without departing from the teachings of the present invention.
As used herein in the specification and claims, including as used in the examples and unless otherwise expressly specified, all numbers may be read as if prefaced by the word “about” or “approximately,” even if the term does not expressly appear. The phrase “about” or “approximately” may be used when describing magnitude and/or position to indicate that the value and/or position described is within a reasonable expected range of values and/or positions. For example, a numeric value may have a value that is +/−0.1% of the stated value (or range of values), +/−1% of the stated value (or range of values), +/−2% of the stated value (or range of values), +/−5% of the stated value (or range of values), +/−10% of the stated value (or range of values), etc. Any numerical range recited herein is intended to include all sub-ranges subsumed therein.
Although various illustrative embodiments are described above, any of a number of changes may be made to various embodiments without departing from the scope of the invention as described by the claims. For example, the order in which various described method steps are performed may often be changed in alternative embodiments, and in other alternative embodiments one or more method steps may be skipped altogether. Optional features of various device and system embodiments may be included in some embodiments and not in others. Therefore, the foregoing description is provided primarily for exemplary purposes and should not be interpreted to limit the scope of the invention as it is set forth in the claims.
The examples and illustrations included herein show, by way of illustration and not of limitation, specific embodiments in which the subject matter may be practiced. As mentioned, other embodiments may be utilized and derived there from, such that structural and logical substitutions and changes may be made without departing from the scope of this disclosure. Such embodiments of the inventive subject matter may be referred to herein individually or collectively by the term “invention” merely for convenience and without intending to voluntarily limit the scope of this application to any single invention or inventive concept, if more than one is, in fact, disclosed. Thus, although specific embodiments have been illustrated and described herein, any arrangement calculated to achieve the same purpose may be substituted for the specific embodiments shown. This disclosure is intended to cover any and all adaptations or variations of various embodiments. Combinations of the above embodiments, and other embodiments not specifically described herein, will be apparent to those of skill in the art upon reviewing the above description.
This application is a continuation of U.S. patent application Ser. No. 17/347,419, filed on Jun. 14, 2021, titled “MICRO-MOLDED ANAMORPHIC REFLECTOR LENS FOR IMAGE GUIDED THERAPEUTIC/DIAGNOSTIC CATHETERS,” now U.S. Patent Application Publication No. 2022/0031168, which is a continuation of U.S. patent application Ser. No. 16/801,047, filed on Feb. 25, 2020, titled “MICRO-MOLDED ANAMORPHIC REFLECTOR LENS FOR IMAGE GUIDED THERAPEUTIC/DIAGNOSTIC CATHETERS,” now U.S. Pat. No. 11,033,190, which is a continuation of U.S. patent application Ser. No. 15/741,928, filed on Jan. 4, 2018, titled “MICRO-MOLDED ANAMORPHIC REFLECTOR LENS FOR IMAGE GUIDED THERAPEUTIC/DIAGNOSTIC CATHETERS,” now U.S. Pat. No. 10,568,520 which is a U.S. National Phase Application Under 35 U.S.C. § 371 of International Application No. PCT/US2016/42152, filed on Jul. 13, 2016, titled “MICRO-MOLDED ANAMORPHIC REFLECTOR LENS FOR IMAGE GUIDED THERAPEUTIC/DIAGNOSTIC CATHETERS,” now International Publication No. WO 2017/011587, which claims priority to U.S. Provisional Patent Application No. 62/191,956, filed Jul. 13, 2015, titled “MICRO-MOLDED ANAMORPHIC REFLECTOR LENS FOR IMAGE GUIDED THERAPEUTIC/DIAGNOSTIC CATHETERS,” and U.S. Provisional Patent Application No. 62/191,986, filed Jul. 13, 2015 and titled “CARBON DIOXIDE CARTRIDGE FOR BALLOON CATHETER,” each of which is incorporated by reference in its entirety. This application may be related to U.S. patent application Ser. No. 14/400,140, filed on Nov. 10, 2014, titled “OPTICAL COHERENCE TOMOGRAPHY WITH GRADED INDEX FIBER FOR BIOLOGICAL IMAGING,” now U.S. Pat. No. 9,557,156, which is incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3367727 | Ward et al. | Feb 1968 | A |
3908637 | Doroshow | Sep 1975 | A |
4178935 | Gekhaman et al. | Dec 1979 | A |
4487206 | Aagard | Dec 1984 | A |
4527553 | Upsher | Jul 1985 | A |
4552554 | Gould et al. | Nov 1985 | A |
4578061 | Lemelson | Mar 1986 | A |
4598710 | Kleinberg et al. | Jul 1986 | A |
4611600 | Cohen | Sep 1986 | A |
4621353 | Hazel et al. | Nov 1986 | A |
4639091 | Huignard et al. | Jan 1987 | A |
4651753 | Lifton | Mar 1987 | A |
4654024 | Crittenden et al. | Mar 1987 | A |
4681106 | Kensey et al. | Jul 1987 | A |
4686982 | Nash | Aug 1987 | A |
4691708 | Kane | Sep 1987 | A |
4729763 | Henrie | Mar 1988 | A |
4771774 | Simpson et al. | Sep 1988 | A |
4781186 | Simpson et al. | Nov 1988 | A |
4808163 | Laub | Feb 1989 | A |
4841977 | Griffith et al. | Jun 1989 | A |
4842578 | Johnson et al. | Jun 1989 | A |
4850354 | McGurk-Burleson et al. | Jul 1989 | A |
4857046 | Stevens et al. | Aug 1989 | A |
4920961 | Grossi et al. | May 1990 | A |
4926858 | Gifford, III et al. | May 1990 | A |
5000185 | Yock | Mar 1991 | A |
5002560 | Machold et al. | Mar 1991 | A |
5018529 | Tenerz et al. | May 1991 | A |
5041082 | Shiber | Aug 1991 | A |
5047040 | Simpson et al. | Sep 1991 | A |
5085662 | Willard | Feb 1992 | A |
5099850 | Matsui et al. | Mar 1992 | A |
5178153 | Einzig | Jan 1993 | A |
5182291 | Gubin et al. | Jan 1993 | A |
5190050 | Nitzsche | Mar 1993 | A |
5192291 | Pannek, Jr. | Mar 1993 | A |
5217479 | Shuler | Jun 1993 | A |
5312415 | Palermo | May 1994 | A |
5312425 | Evans et al. | May 1994 | A |
5321501 | Swanson et al. | Jun 1994 | A |
5333142 | Scheps | Jul 1994 | A |
5358472 | Vance et al. | Oct 1994 | A |
5366464 | Belknap | Nov 1994 | A |
5372601 | Lary | Dec 1994 | A |
5383460 | Jang et al. | Jan 1995 | A |
5383467 | Auer et al. | Jan 1995 | A |
5425273 | Chevalier | Jun 1995 | A |
5425371 | Mischenko | Jun 1995 | A |
5429136 | Milo et al. | Jul 1995 | A |
5431673 | Summers et al. | Jul 1995 | A |
5437284 | Trimble | Aug 1995 | A |
5449372 | Schmaltz et al. | Sep 1995 | A |
5459570 | Swanson et al. | Oct 1995 | A |
5460168 | Masubuchi et al. | Oct 1995 | A |
5465147 | Swanson | Nov 1995 | A |
5507725 | Savage et al. | Apr 1996 | A |
5507760 | Wynne et al. | Apr 1996 | A |
5507795 | Chiang et al. | Apr 1996 | A |
5517998 | Madison | May 1996 | A |
5529580 | Kusunok et al. | Jun 1996 | A |
5556405 | Lary | Sep 1996 | A |
5607394 | Andersen et al. | Mar 1997 | A |
5613981 | Boyle et al. | Mar 1997 | A |
5620426 | Braithwaite | Apr 1997 | A |
5632754 | Farley et al. | May 1997 | A |
5632755 | Nordgren et al. | May 1997 | A |
5674232 | Halliburton | Oct 1997 | A |
5676012 | Ceriale | Oct 1997 | A |
5681336 | Clement et al. | Oct 1997 | A |
5690634 | Muller et al. | Nov 1997 | A |
5722403 | McGee et al. | Mar 1998 | A |
5728148 | Bostrom et al. | Mar 1998 | A |
5749846 | Edwards et al. | May 1998 | A |
5795295 | Hellmuth et al. | Aug 1998 | A |
5807339 | Bostrom et al. | Sep 1998 | A |
5830145 | Tenhoff | Nov 1998 | A |
5836957 | Schulz et al. | Nov 1998 | A |
5843050 | Jones et al. | Dec 1998 | A |
5843103 | Wulfman | Dec 1998 | A |
5851212 | Zirps et al. | Dec 1998 | A |
5868778 | Gershony et al. | Feb 1999 | A |
5872879 | Hamm | Feb 1999 | A |
5904651 | Swanson et al. | May 1999 | A |
5907425 | Dickensheets et al. | May 1999 | A |
5935075 | Casscells et al. | Aug 1999 | A |
5935139 | Bates | Aug 1999 | A |
5938602 | Lloyd | Aug 1999 | A |
5938671 | Katoh et al. | Aug 1999 | A |
5951482 | Winston et al. | Sep 1999 | A |
5951581 | Saadat et al. | Sep 1999 | A |
5951583 | Jensen et al. | Sep 1999 | A |
5956355 | Swanson et al. | Sep 1999 | A |
5957952 | Gershony et al. | Sep 1999 | A |
5987995 | Sawatari et al. | Nov 1999 | A |
5997558 | Nash | Dec 1999 | A |
6001112 | Taylor | Dec 1999 | A |
6007530 | Domhofer et al. | Dec 1999 | A |
6010449 | Selmon et al. | Jan 2000 | A |
6013072 | Winston et al. | Jan 2000 | A |
6017359 | Gershony et al. | Jan 2000 | A |
6027514 | Stine et al. | Feb 2000 | A |
6032673 | Savage et al. | Mar 2000 | A |
6048349 | Winston et al. | Apr 2000 | A |
6080170 | Nash et al. | Jun 2000 | A |
6106515 | Winston et al. | Aug 2000 | A |
6110164 | Vidlund | Aug 2000 | A |
6120515 | Rogers et al. | Sep 2000 | A |
6120516 | Selmon et al. | Sep 2000 | A |
6134002 | Stimson et al. | Oct 2000 | A |
6134003 | Tearney et al. | Oct 2000 | A |
6152938 | Curry | Nov 2000 | A |
6152951 | Hashimoto et al. | Nov 2000 | A |
6160826 | Swanson et al. | Dec 2000 | A |
6175669 | Colston et al. | Jan 2001 | B1 |
6176871 | Pathak et al. | Jan 2001 | B1 |
6183432 | Milo | Feb 2001 | B1 |
6193676 | Winston et al. | Feb 2001 | B1 |
6206898 | Honeycutt et al. | Mar 2001 | B1 |
6228076 | Winston et al. | May 2001 | B1 |
6241744 | Imran et al. | Jun 2001 | B1 |
6283957 | Hashimoto et al. | Sep 2001 | B1 |
6285903 | Rosenthal et al. | Sep 2001 | B1 |
6290668 | Gregory et al. | Sep 2001 | B1 |
6294775 | Seibel et al. | Sep 2001 | B1 |
6299622 | Snow et al. | Oct 2001 | B1 |
6307985 | Murakami et al. | Oct 2001 | B1 |
6375615 | Flaherty et al. | Apr 2002 | B1 |
6402719 | Ponzi et al. | Jun 2002 | B1 |
6416527 | Berg et al. | Jul 2002 | B1 |
6445939 | Swanson et al. | Sep 2002 | B1 |
6445944 | Ostrovsky | Sep 2002 | B1 |
6447525 | Follmer et al. | Sep 2002 | B2 |
6451009 | Dasilva et al. | Sep 2002 | B1 |
6451036 | Heitzmann et al. | Sep 2002 | B1 |
6454717 | Pantages et al. | Sep 2002 | B1 |
6454779 | Taylor | Sep 2002 | B1 |
6482216 | Hiblar et al. | Nov 2002 | B1 |
6482217 | Pintor et al. | Nov 2002 | B1 |
6485413 | Boppart et al. | Nov 2002 | B1 |
6497649 | Parker et al. | Dec 2002 | B2 |
6501551 | Tearney et al. | Dec 2002 | B1 |
6503261 | Bruneau et al. | Jan 2003 | B1 |
6511458 | Milo et al. | Jan 2003 | B2 |
6517528 | Pantages et al. | Feb 2003 | B1 |
6542665 | Reed et al. | Apr 2003 | B2 |
6544230 | Flaherty et al. | Apr 2003 | B1 |
6546272 | MacKinnon et al. | Apr 2003 | B1 |
6551302 | Rosinko et al. | Apr 2003 | B1 |
6563105 | Seibel et al. | May 2003 | B2 |
6564087 | Pitris et al. | May 2003 | B1 |
6565588 | Clement et al. | May 2003 | B1 |
6572563 | Ouchi et al. | Jun 2003 | B2 |
6572643 | Gharibadeh | Jun 2003 | B1 |
6575995 | Huter et al. | Jun 2003 | B1 |
6579298 | Bruneau et al. | Jun 2003 | B1 |
6599296 | Gillick et al. | Jul 2003 | B1 |
6615071 | Casscells, III et al. | Sep 2003 | B1 |
6629953 | Boyd | Oct 2003 | B1 |
6638233 | Corvi et al. | Oct 2003 | B2 |
6645217 | MacKinnon et al. | Nov 2003 | B1 |
6657727 | Izatt et al. | Dec 2003 | B1 |
6666874 | Heitzmann et al. | Dec 2003 | B2 |
6673042 | Samson et al. | Jan 2004 | B1 |
6687010 | Horii | Feb 2004 | B1 |
6728571 | Barbato | Apr 2004 | B1 |
D489973 | Root et al. | May 2004 | S |
6730063 | Delaney et al. | May 2004 | B2 |
6758854 | Butler et al. | Jul 2004 | B1 |
6760112 | Reed et al. | Jul 2004 | B2 |
6800085 | Selmon et al. | Oct 2004 | B2 |
6818001 | Wulfman et al. | Nov 2004 | B2 |
6824550 | Noriega et al. | Nov 2004 | B1 |
6830577 | Nash et al. | Dec 2004 | B2 |
6845190 | Smithwick et al. | Jan 2005 | B1 |
6852109 | Winston et al. | Feb 2005 | B2 |
6853457 | Bjarklev et al. | Feb 2005 | B2 |
6856712 | Fauver et al. | Feb 2005 | B2 |
6867753 | Chinthammit et al. | Mar 2005 | B2 |
6879851 | McNamara et al. | Apr 2005 | B2 |
6947787 | Webler | Sep 2005 | B2 |
6961123 | Wang et al. | Nov 2005 | B1 |
6970732 | Winston et al. | Nov 2005 | B2 |
6975898 | Seibel | Dec 2005 | B2 |
7068878 | Crossman-Bosworth et al. | Jun 2006 | B2 |
7074231 | Jang | Jul 2006 | B2 |
7126693 | Everett et al. | Oct 2006 | B2 |
7172610 | Heitzmann et al. | Feb 2007 | B2 |
7242480 | Alphonse | Jul 2007 | B2 |
7261687 | Yang | Aug 2007 | B2 |
7288087 | Winston et al. | Oct 2007 | B2 |
7291146 | Steinke et al. | Nov 2007 | B2 |
7297131 | Nita | Nov 2007 | B2 |
7311723 | Seibel et al. | Dec 2007 | B2 |
7344546 | Wulfman et al. | Mar 2008 | B2 |
7366376 | Shishkov et al. | Apr 2008 | B2 |
7382949 | Bouma et al. | Jun 2008 | B2 |
7426036 | Feldchtein et al. | Sep 2008 | B2 |
7428001 | Schowengerdt et al. | Sep 2008 | B2 |
7428053 | Feldchtein et al. | Sep 2008 | B2 |
7455649 | Root et al. | Nov 2008 | B2 |
7474407 | Gutin | Jan 2009 | B2 |
7485127 | Nistal | Feb 2009 | B2 |
7488340 | Kauphusman et al. | Feb 2009 | B2 |
7530948 | Seibel et al. | May 2009 | B2 |
7530976 | MacMahon et al. | May 2009 | B2 |
7538859 | Tearney et al. | May 2009 | B2 |
7538886 | Feldchtein | May 2009 | B2 |
7539362 | Teramura | May 2009 | B2 |
7542145 | Toida et al. | Jun 2009 | B2 |
7544162 | Ohkubo | Jun 2009 | B2 |
7545504 | Buckland et al. | Jun 2009 | B2 |
7555333 | Wang et al. | Jun 2009 | B2 |
7577471 | Camus et al. | Aug 2009 | B2 |
7583872 | Seibel et al. | Sep 2009 | B2 |
7616986 | Seibel et al. | Nov 2009 | B2 |
7637885 | Maschke | Dec 2009 | B2 |
7674253 | Fisher et al. | Mar 2010 | B2 |
7682319 | Martin et al. | Mar 2010 | B2 |
7706863 | Imanishi et al. | Apr 2010 | B2 |
7728985 | Feldchtein et al. | Jun 2010 | B2 |
7729745 | Maschke | Jun 2010 | B2 |
7734332 | Sher | Jun 2010 | B2 |
7738945 | Fauver et al. | Jun 2010 | B2 |
7753852 | Maschke | Jul 2010 | B2 |
7771425 | Dycus et al. | Aug 2010 | B2 |
7776062 | Bessellink et al. | Aug 2010 | B2 |
7785286 | Magnin et al. | Aug 2010 | B2 |
7813609 | Petersen et al. | Oct 2010 | B2 |
7821643 | Amazeen et al. | Oct 2010 | B2 |
7824089 | Charles | Nov 2010 | B2 |
7840283 | Bush et al. | Nov 2010 | B1 |
7944568 | Teramura et al. | May 2011 | B2 |
7952718 | Li et al. | May 2011 | B2 |
7972299 | Carter et al. | Jul 2011 | B2 |
8002763 | Berthiaume et al. | Aug 2011 | B2 |
8059274 | Splinter | Nov 2011 | B2 |
8062316 | Patel et al. | Nov 2011 | B2 |
8068921 | Prakash et al. | Nov 2011 | B2 |
8313493 | Fisher | Nov 2012 | B2 |
8361097 | Patel et al. | Jan 2013 | B2 |
8548571 | He et al. | Oct 2013 | B2 |
8548603 | Swoyer et al. | Oct 2013 | B2 |
8632557 | Thatcher et al. | Jan 2014 | B2 |
8644913 | Simpson et al. | Feb 2014 | B2 |
8647335 | Markus | Feb 2014 | B2 |
8696695 | Patel et al. | Apr 2014 | B2 |
8911459 | Simpson et al. | Dec 2014 | B2 |
9119662 | Moberg | Sep 2015 | B2 |
9125562 | Spencer et al. | Sep 2015 | B2 |
9333007 | Escudero et al. | May 2016 | B2 |
9345398 | Tachibana et al. | May 2016 | B2 |
9345406 | Spencer et al. | May 2016 | B2 |
9345510 | Patel et al. | May 2016 | B2 |
9345511 | Smith et al. | May 2016 | B2 |
9351757 | Kusleika | May 2016 | B2 |
9498247 | Patel et al. | Nov 2016 | B2 |
9498600 | Rosenthal et al. | Nov 2016 | B2 |
9557156 | Kankaria | Jan 2017 | B2 |
9572492 | Simpson et al. | Feb 2017 | B2 |
9579157 | Moberg | Feb 2017 | B2 |
9592075 | Simpson et al. | Mar 2017 | B2 |
9642646 | Patel et al. | May 2017 | B2 |
9788790 | Black et al. | Oct 2017 | B2 |
9854979 | Smith et al. | Jan 2018 | B2 |
9918734 | Patel et al. | Mar 2018 | B2 |
9949754 | Newhauser et al. | Apr 2018 | B2 |
10052125 | Rosenthal et al. | Aug 2018 | B2 |
10130386 | Simpson et al. | Nov 2018 | B2 |
10213224 | Guggenheimer et al. | Feb 2019 | B2 |
10244934 | Tachibana et al. | Apr 2019 | B2 |
10314667 | Garvey et al. | Jun 2019 | B2 |
10335173 | Carver et al. | Jul 2019 | B2 |
10342491 | Black et al. | Jul 2019 | B2 |
10349974 | Patel et al. | Jul 2019 | B2 |
10357277 | Patel et al. | Jul 2019 | B2 |
10363062 | Spencer et al. | Jul 2019 | B2 |
10406316 | Garvey et al. | Sep 2019 | B2 |
10470795 | Patel et al. | Nov 2019 | B2 |
10548478 | Simpson et al. | Feb 2020 | B2 |
10568520 | Patel et al. | Feb 2020 | B2 |
10568655 | Simpson et al. | Feb 2020 | B2 |
10722121 | Smith et al. | Jul 2020 | B2 |
10729326 | Spencer et al. | Aug 2020 | B2 |
10806484 | Simpson et al. | Oct 2020 | B2 |
10869685 | Patel et al. | Dec 2020 | B2 |
10932670 | Smith et al. | Mar 2021 | B2 |
10952615 | Kankaria | Mar 2021 | B2 |
10952763 | Newhauser et al. | Mar 2021 | B2 |
11033190 | Patel et al. | Jun 2021 | B2 |
11076773 | Patel et al. | Aug 2021 | B2 |
11096717 | Gupta et al. | Aug 2021 | B2 |
11134849 | Simpson et al. | Oct 2021 | B2 |
11135019 | Spencer et al. | Oct 2021 | B2 |
11147583 | Patel et al. | Oct 2021 | B2 |
11206975 | Tachibana et al. | Dec 2021 | B2 |
11224459 | Patel et al. | Jan 2022 | B2 |
11278248 | Christensen | Mar 2022 | B2 |
11284839 | Black et al. | Mar 2022 | B2 |
11284916 | Patel et al. | Mar 2022 | B2 |
11344327 | Fernandez et al. | May 2022 | B2 |
11382653 | Patel et al. | Jul 2022 | B2 |
11399863 | Patel et al. | Aug 2022 | B2 |
11406412 | Gupta et al. | Aug 2022 | B2 |
11627881 | Patel et al. | Apr 2023 | B2 |
11647905 | Kankaria | May 2023 | B2 |
20010005788 | McGuckin, Jr. | Jun 2001 | A1 |
20010020126 | Swanson et al. | Sep 2001 | A1 |
20020019644 | Hastings et al. | Feb 2002 | A1 |
20020072706 | Hiblar et al. | Jun 2002 | A1 |
20020082585 | Carroll et al. | Jun 2002 | A1 |
20020082626 | Donohoe et al. | Jun 2002 | A1 |
20020097400 | Jung et al. | Jul 2002 | A1 |
20020111548 | Swanson et al. | Aug 2002 | A1 |
20020115931 | Strauss et al. | Aug 2002 | A1 |
20020138091 | Pflueger | Sep 2002 | A1 |
20020147459 | Bashiri et al. | Oct 2002 | A1 |
20020158547 | Wood | Oct 2002 | A1 |
20030002038 | Mawatari | Jan 2003 | A1 |
20030028100 | Tearney et al. | Feb 2003 | A1 |
20030032880 | Moore | Feb 2003 | A1 |
20030045835 | Anderson et al. | Mar 2003 | A1 |
20030095248 | Frot | May 2003 | A1 |
20030097044 | Rovegno | May 2003 | A1 |
20030120150 | Govari | Jun 2003 | A1 |
20030120295 | Simpson et al. | Jun 2003 | A1 |
20030125756 | Shturman et al. | Jul 2003 | A1 |
20030125757 | Patel et al. | Jul 2003 | A1 |
20030125758 | Simpson et al. | Jul 2003 | A1 |
20030139751 | Evans et al. | Jul 2003 | A1 |
20030181855 | Simpson et al. | Sep 2003 | A1 |
20040002650 | Mandrusov et al. | Jan 2004 | A1 |
20040039371 | Tockman et al. | Feb 2004 | A1 |
20040057667 | Yamada et al. | Mar 2004 | A1 |
20040059257 | Gaber | Mar 2004 | A1 |
20040082850 | Bonner et al. | Apr 2004 | A1 |
20040092915 | Levatter | May 2004 | A1 |
20040093001 | Hamada | May 2004 | A1 |
20040147934 | Kiester | Jul 2004 | A1 |
20040167553 | Simpson et al. | Aug 2004 | A1 |
20040167554 | Simpson et al. | Aug 2004 | A1 |
20040181249 | Torrance et al. | Sep 2004 | A1 |
20040186368 | Ramzipoor et al. | Sep 2004 | A1 |
20040193140 | Griffin et al. | Sep 2004 | A1 |
20040202418 | Ghiron et al. | Oct 2004 | A1 |
20040220519 | Wulfman et al. | Nov 2004 | A1 |
20040230212 | Wulfman | Nov 2004 | A1 |
20040230213 | Wulfman et al. | Nov 2004 | A1 |
20040236312 | Nistal et al. | Nov 2004 | A1 |
20040243162 | Wulfman et al. | Dec 2004 | A1 |
20040254599 | Lipoma et al. | Dec 2004 | A1 |
20040260236 | Manning et al. | Dec 2004 | A1 |
20050020925 | Kleen et al. | Jan 2005 | A1 |
20050021075 | Bonnette et al. | Jan 2005 | A1 |
20050027199 | Clarke | Feb 2005 | A1 |
20050043614 | Huizenga et al. | Feb 2005 | A1 |
20050054947 | Goldenberg | Mar 2005 | A1 |
20050075660 | Chu et al. | Apr 2005 | A1 |
20050085708 | Fauver et al. | Apr 2005 | A1 |
20050085721 | Fauver et al. | Apr 2005 | A1 |
20050105097 | Fang-Yen et al. | May 2005 | A1 |
20050141843 | Warden et al. | Jun 2005 | A1 |
20050149096 | Hilal et al. | Jul 2005 | A1 |
20050154407 | Simpson | Jul 2005 | A1 |
20050159712 | Andersen | Jul 2005 | A1 |
20050159731 | Lee | Jul 2005 | A1 |
20050171478 | Selmon et al. | Aug 2005 | A1 |
20050177068 | Simpson | Aug 2005 | A1 |
20050182295 | Soper et al. | Aug 2005 | A1 |
20050187571 | Maschke | Aug 2005 | A1 |
20050192496 | Maschke | Sep 2005 | A1 |
20050197623 | Leeflang et al. | Sep 2005 | A1 |
20050201662 | Petersen et al. | Sep 2005 | A1 |
20050203553 | Maschke | Sep 2005 | A1 |
20050222519 | Simpson | Oct 2005 | A1 |
20050222663 | Simpson et al. | Oct 2005 | A1 |
20050251116 | Steinke et al. | Nov 2005 | A1 |
20060011820 | Chow-Shing et al. | Jan 2006 | A1 |
20060032508 | Simpson | Feb 2006 | A1 |
20060046235 | Alexander | Mar 2006 | A1 |
20060049587 | Cornwell | Mar 2006 | A1 |
20060064009 | Webler et al. | Mar 2006 | A1 |
20060084911 | Belef et al. | Apr 2006 | A1 |
20060109478 | Tearney et al. | May 2006 | A1 |
20060135870 | Webler | Jun 2006 | A1 |
20060173475 | Lafontaine et al. | Aug 2006 | A1 |
20060229646 | Sparks | Oct 2006 | A1 |
20060229659 | Gifford et al. | Oct 2006 | A1 |
20060235262 | Arnal et al. | Oct 2006 | A1 |
20060235366 | Simpson | Oct 2006 | A1 |
20060236019 | Soito et al. | Oct 2006 | A1 |
20060239982 | Simpson | Oct 2006 | A1 |
20060241503 | Schmitt et al. | Oct 2006 | A1 |
20060244973 | Yun et al. | Nov 2006 | A1 |
20060252993 | Freed et al. | Nov 2006 | A1 |
20060264741 | Prince | Nov 2006 | A1 |
20060264743 | Kleen et al. | Nov 2006 | A1 |
20060264907 | Eskridge et al. | Nov 2006 | A1 |
20070010840 | Rosenthal et al. | Jan 2007 | A1 |
20070015969 | Feldman et al. | Jan 2007 | A1 |
20070015979 | Redel | Jan 2007 | A1 |
20070035855 | Dickensheets | Feb 2007 | A1 |
20070038061 | Huennekens et al. | Feb 2007 | A1 |
20070038125 | Kleen et al. | Feb 2007 | A1 |
20070038173 | Simpson | Feb 2007 | A1 |
20070050019 | Hyde | Mar 2007 | A1 |
20070078469 | Soito et al. | Apr 2007 | A1 |
20070078500 | Ryan et al. | Apr 2007 | A1 |
20070081166 | Brown et al. | Apr 2007 | A1 |
20070088230 | Terashi et al. | Apr 2007 | A1 |
20070106155 | Goodnow et al. | May 2007 | A1 |
20070135712 | Maschke | Jun 2007 | A1 |
20070167710 | Unal et al. | Jul 2007 | A1 |
20070196926 | Soito et al. | Aug 2007 | A1 |
20070213618 | Li et al. | Sep 2007 | A1 |
20070219484 | Straub | Sep 2007 | A1 |
20070250080 | Jones et al. | Oct 2007 | A1 |
20070255252 | Mehta | Nov 2007 | A1 |
20070270647 | Nahen et al. | Nov 2007 | A1 |
20070276419 | Rosenthal | Nov 2007 | A1 |
20070288036 | Seshadri | Dec 2007 | A1 |
20070299309 | Seibel et al. | Dec 2007 | A1 |
20080004643 | To et al. | Jan 2008 | A1 |
20080004644 | To et al. | Jan 2008 | A1 |
20080004645 | To et al. | Jan 2008 | A1 |
20080004646 | To et al. | Jan 2008 | A1 |
20080015491 | Bei et al. | Jan 2008 | A1 |
20080015618 | Sonnenschein et al. | Jan 2008 | A1 |
20080027334 | Langston | Jan 2008 | A1 |
20080033396 | Danek et al. | Feb 2008 | A1 |
20080045986 | To et al. | Feb 2008 | A1 |
20080049234 | Seitz | Feb 2008 | A1 |
20080058629 | Seibel et al. | Mar 2008 | A1 |
20080065124 | Olson | Mar 2008 | A1 |
20080065125 | Olson | Mar 2008 | A1 |
20080065205 | Nguyen et al. | Mar 2008 | A1 |
20080095421 | Sun et al. | Apr 2008 | A1 |
20080103439 | Torrance et al. | May 2008 | A1 |
20080103446 | Torrance et al. | May 2008 | A1 |
20080103516 | Wulfman et al. | May 2008 | A1 |
20080132929 | O'Sullivan et al. | Jun 2008 | A1 |
20080139897 | Ainsworth et al. | Jun 2008 | A1 |
20080146942 | Dala-Krishna | Jun 2008 | A1 |
20080147000 | Seibel et al. | Jun 2008 | A1 |
20080154293 | Taylor et al. | Jun 2008 | A1 |
20080154296 | Taylor et al. | Jun 2008 | A1 |
20080177138 | Courtney et al. | Jul 2008 | A1 |
20080186501 | Xie | Aug 2008 | A1 |
20080207996 | Tsai | Aug 2008 | A1 |
20080221388 | Seibel et al. | Sep 2008 | A1 |
20080228033 | Tumlinson et al. | Sep 2008 | A1 |
20080243030 | Seibel et al. | Oct 2008 | A1 |
20080243031 | Seibel et al. | Oct 2008 | A1 |
20080262312 | Carroll et al. | Oct 2008 | A1 |
20080275485 | Bonnette et al. | Nov 2008 | A1 |
20080287795 | Klingensmith et al. | Nov 2008 | A1 |
20090018565 | To et al. | Jan 2009 | A1 |
20090018566 | Escudero et al. | Jan 2009 | A1 |
20090018567 | Escudero et al. | Jan 2009 | A1 |
20090024084 | Khosla et al. | Jan 2009 | A1 |
20090024085 | To et al. | Jan 2009 | A1 |
20090024191 | Seibel et al. | Jan 2009 | A1 |
20090028407 | Seibel et al. | Jan 2009 | A1 |
20090028507 | Jones et al. | Jan 2009 | A1 |
20090043191 | Castella et al. | Feb 2009 | A1 |
20090073444 | Wang | Mar 2009 | A1 |
20090073455 | Onimura | Mar 2009 | A1 |
20090076447 | Casas et al. | Mar 2009 | A1 |
20090093764 | Pfeffer et al. | Apr 2009 | A1 |
20090099641 | Wu et al. | Apr 2009 | A1 |
20090125019 | Douglass et al. | May 2009 | A1 |
20090135280 | Johnston et al. | May 2009 | A1 |
20090137893 | Seibel et al. | May 2009 | A1 |
20090152664 | Tian et al. | Jun 2009 | A1 |
20090185135 | Volk | Jul 2009 | A1 |
20090196477 | Cense et al. | Aug 2009 | A1 |
20090196554 | Irisawa | Aug 2009 | A1 |
20090198125 | Nakabayashi et al. | Aug 2009 | A1 |
20090208143 | Yoon et al. | Aug 2009 | A1 |
20090216180 | Lee et al. | Aug 2009 | A1 |
20090221904 | Shealy et al. | Sep 2009 | A1 |
20090221920 | Boppart et al. | Sep 2009 | A1 |
20090234220 | Maschke | Sep 2009 | A1 |
20090235396 | Wang et al. | Sep 2009 | A1 |
20090244485 | Walsh et al. | Oct 2009 | A1 |
20090244547 | Ozawa | Oct 2009 | A1 |
20090264826 | Thompson | Oct 2009 | A1 |
20090268159 | Xu et al. | Oct 2009 | A1 |
20090275966 | Mitusina | Nov 2009 | A1 |
20090284749 | Johnson et al. | Nov 2009 | A1 |
20090292199 | Bielewicz et al. | Nov 2009 | A1 |
20090306520 | Schmitt et al. | Dec 2009 | A1 |
20090316116 | Melville et al. | Dec 2009 | A1 |
20090318862 | Ali et al. | Dec 2009 | A1 |
20100004544 | Toida | Jan 2010 | A1 |
20100021926 | Noordin | Jan 2010 | A1 |
20100049225 | To et al. | Feb 2010 | A1 |
20100080016 | Fukui et al. | Apr 2010 | A1 |
20100082000 | Honeck et al. | Apr 2010 | A1 |
20100125253 | Olson | May 2010 | A1 |
20100130996 | Doud et al. | May 2010 | A1 |
20100198081 | Hanlin et al. | Aug 2010 | A1 |
20100217245 | Prescott | Aug 2010 | A1 |
20100241147 | Maschke | Sep 2010 | A1 |
20100253949 | Adler et al. | Oct 2010 | A1 |
20100292539 | Lankenau et al. | Nov 2010 | A1 |
20100292721 | Moberg | Nov 2010 | A1 |
20100312263 | Moberg et al. | Dec 2010 | A1 |
20100317973 | Nita | Dec 2010 | A1 |
20100324472 | Wulfman | Dec 2010 | A1 |
20110021926 | Spencer | Jan 2011 | A1 |
20110023617 | Yu et al. | Feb 2011 | A1 |
20110028977 | Rauscher et al. | Feb 2011 | A1 |
20110040238 | Wulfman et al. | Feb 2011 | A1 |
20110058250 | Liu et al. | Mar 2011 | A1 |
20110060186 | Tilson et al. | Mar 2011 | A1 |
20110071401 | Hastings et al. | Mar 2011 | A1 |
20110092955 | Purdy et al. | Apr 2011 | A1 |
20110106004 | Eubanks et al. | May 2011 | A1 |
20110118660 | Torrance et al. | May 2011 | A1 |
20110130777 | Zhang et al. | Jun 2011 | A1 |
20110137140 | Tearney et al. | Jun 2011 | A1 |
20110144673 | Zhang et al. | Jun 2011 | A1 |
20110201924 | Tearney et al. | Aug 2011 | A1 |
20110208222 | Ljahnicky et al. | Aug 2011 | A1 |
20110257478 | Kleiner et al. | Oct 2011 | A1 |
20110264125 | Wilson et al. | Oct 2011 | A1 |
20110270187 | Nelson | Nov 2011 | A1 |
20110295148 | Destoumieux et al. | Dec 2011 | A1 |
20110301625 | Mauch et al. | Dec 2011 | A1 |
20110319905 | Palme et al. | Dec 2011 | A1 |
20120002928 | Irisawa | Jan 2012 | A1 |
20120004506 | Tearney et al. | Jan 2012 | A1 |
20120123352 | Fruland et al. | May 2012 | A1 |
20120136350 | Goshgarian et al. | May 2012 | A1 |
20120203230 | Adams | Aug 2012 | A1 |
20120238869 | Schmitt et al. | Sep 2012 | A1 |
20120259337 | del Rio et al. | Oct 2012 | A1 |
20120277730 | Salahieh et al. | Nov 2012 | A1 |
20120289971 | Segermark et al. | Nov 2012 | A1 |
20130023865 | Steinke et al. | Jan 2013 | A1 |
20130035692 | Sorensen et al. | Feb 2013 | A1 |
20130072787 | Wallace et al. | Mar 2013 | A1 |
20130184549 | Avitall et al. | Jul 2013 | A1 |
20130211221 | Sunnarborg et al. | Aug 2013 | A1 |
20130223798 | Jenner et al. | Aug 2013 | A1 |
20130223801 | Bhagavatula et al. | Aug 2013 | A1 |
20130255069 | Higashi et al. | Oct 2013 | A1 |
20130266259 | Bhagavatula et al. | Oct 2013 | A1 |
20130287282 | Yokota et al. | Oct 2013 | A1 |
20130317519 | Romo et al. | Nov 2013 | A1 |
20130325003 | Kapur et al. | Dec 2013 | A1 |
20130331819 | Rosenman et al. | Dec 2013 | A1 |
20140005534 | He et al. | Jan 2014 | A1 |
20140046250 | Jain et al. | Feb 2014 | A1 |
20140128893 | Guggenheimer et al. | May 2014 | A1 |
20140187949 | Zhao et al. | Jul 2014 | A1 |
20140222042 | Kessler et al. | Aug 2014 | A1 |
20140222047 | Vreeman | Aug 2014 | A1 |
20140243881 | Lees et al. | Aug 2014 | A1 |
20140275996 | Stigall | Sep 2014 | A1 |
20140291985 | Cabrera et al. | Oct 2014 | A1 |
20140343410 | Graf et al. | Nov 2014 | A1 |
20140371718 | Alvarez et al. | Dec 2014 | A1 |
20150025310 | Everingham et al. | Jan 2015 | A1 |
20150036146 | Staloff | Feb 2015 | A1 |
20150146211 | Bhagavatula et al. | May 2015 | A1 |
20150320975 | Simpson et al. | Nov 2015 | A1 |
20150327866 | Eckhouse et al. | Nov 2015 | A1 |
20160144155 | Simpson et al. | May 2016 | A1 |
20160310700 | Drake et al. | Oct 2016 | A1 |
20160354109 | Guggenheimer et al. | Dec 2016 | A1 |
20160354110 | Guggenheimer et al. | Dec 2016 | A1 |
20170172666 | Govari et al. | Jun 2017 | A1 |
20180207417 | Zung et al. | Jul 2018 | A1 |
20180364024 | Baca et al. | Dec 2018 | A1 |
20190110809 | Rosenthal et al. | Apr 2019 | A1 |
20190313941 | Radjabi | Oct 2019 | A1 |
20210059713 | Patel et al. | Mar 2021 | A1 |
20210076949 | Smith et al. | Mar 2021 | A1 |
20210177262 | Spencer et al. | Jun 2021 | A1 |
20210267621 | Simpson et al. | Sep 2021 | A1 |
20210330345 | Newhauser et al. | Oct 2021 | A1 |
20210345903 | Patel et al. | Nov 2021 | A1 |
20220039658 | Smith et al. | Feb 2022 | A1 |
20220039828 | Patel et al. | Feb 2022 | A1 |
20220071656 | Patel et al. | Mar 2022 | A1 |
20220079617 | Gupta et al. | Mar 2022 | A1 |
20220095926 | Simpson et al. | Mar 2022 | A1 |
20220125525 | Spencer et al. | Apr 2022 | A1 |
20220168011 | Patel et al. | Jun 2022 | A1 |
20220183545 | Tachibana et al. | Jun 2022 | A1 |
20220240860 | Black et al. | Aug 2022 | A1 |
20220273336 | Fernandez et al. | Sep 2022 | A1 |
20220273337 | Patel et al. | Sep 2022 | A1 |
20220323099 | Patel et al. | Oct 2022 | A1 |
20220346638 | Patel | Nov 2022 | A1 |
20230329746 | Rosenthal et al. | Oct 2023 | A1 |
Number | Date | Country |
---|---|---|
1875242 | Dec 2006 | CN |
1947652 | Apr 2007 | CN |
101601581 | Dec 2009 | CN |
103027727 | Apr 2013 | CN |
104968285 | Oct 2015 | CN |
202006018883.5 | Feb 2007 | DE |
0347098 | Dec 1989 | EP |
0808638 | Nov 1997 | EP |
0845692 | Nov 2005 | EP |
1859732 | Nov 2007 | EP |
2090245 | Aug 2009 | EP |
2353526 | Sep 2013 | EP |
2942028 | Nov 2015 | EP |
3446648 | Feb 2019 | EP |
S62-275425 | Nov 1987 | JP |
03502060 | Feb 1990 | JP |
H05501065 | Mar 1993 | JP |
05103763 | Apr 1993 | JP |
06027343 | Feb 1994 | JP |
H07184888 | Jul 1995 | JP |
07308393 | Nov 1995 | JP |
2002214127 | Jul 2002 | JP |
2004509695 | Apr 2004 | JP |
2004516073 | Jun 2004 | JP |
2005114473 | Apr 2005 | JP |
2005230550 | Sep 2005 | JP |
2005249704 | Sep 2005 | JP |
2005533533 | Nov 2005 | JP |
2008175698 | Jul 2006 | JP |
2006288775 | Oct 2006 | JP |
2006313158 | Nov 2006 | JP |
2006526790 | Nov 2006 | JP |
2006326157 | Dec 2006 | JP |
200783053 | Apr 2007 | JP |
200783057 | Apr 2007 | JP |
2007225349 | Sep 2007 | JP |
2007533361 | Nov 2007 | JP |
2008023627 | Feb 2008 | JP |
2008128708 | Jun 2008 | JP |
2008145376 | Jun 2008 | JP |
2008183208 | Aug 2008 | JP |
2008253492 | Oct 2008 | JP |
200914751 | Jan 2009 | JP |
2009509690 | Mar 2009 | JP |
200978150 | Apr 2009 | JP |
2009066252 | Apr 2009 | JP |
2009201969 | Sep 2009 | JP |
2010042182 | Feb 2010 | JP |
2010518900 | Jun 2010 | JP |
2011521747 | Jul 2011 | JP |
2012143558 | Aug 2012 | JP |
2012229976 | Nov 2012 | JP |
2012533353 | Dec 2012 | JP |
2013512736 | Apr 2013 | JP |
2013524930 | Jun 2013 | JP |
2015533584 | Nov 2015 | JP |
2016508758 | Mar 2016 | JP |
20070047221 | May 2007 | KR |
2185859 | Jul 2002 | RU |
2218191 | Dec 2003 | RU |
WO9117698 | Nov 1991 | WO |
WO9923958 | May 1999 | WO |
WO0054659 | Sep 2000 | WO |
WO0115609 | Mar 2001 | WO |
WO0176680 | Oct 2001 | WO |
WO2006133030 | Dec 2006 | WO |
WO2008005888 | Jan 2008 | WO |
WO2008029506 | Mar 2008 | WO |
WO2008042987 | Apr 2008 | WO |
WO2008051951 | May 2008 | WO |
WO2008065600 | Jun 2008 | WO |
WO2008086613 | Jul 2008 | WO |
WO2008087613 | Jul 2008 | WO |
WO2008151155 | Dec 2008 | WO |
WO2009005779 | Jan 2009 | WO |
WO2009006335 | Jan 2009 | WO |
WO2009009799 | Jan 2009 | WO |
WO2009009802 | Jan 2009 | WO |
WO2009023635 | Feb 2009 | WO |
WO2009024344 | Feb 2009 | WO |
WO2009094341 | Jul 2009 | WO |
WO2009140617 | Nov 2009 | WO |
WO2009148317 | Dec 2009 | WO |
WO2010039464 | Apr 2010 | WO |
WO2010056771 | May 2010 | WO |
WO2011044387 | Apr 2011 | WO |
WO2011062087 | May 2011 | WO |
WO2012057940 | May 2012 | WO |
WO2012061935 | May 2012 | WO |
WO2012123737 | Sep 2012 | WO |
WO2012166332 | Dec 2012 | WO |
WO2013033490 | Mar 2013 | WO |
WO2013056262 | Apr 2013 | WO |
WO2014077870 | May 2014 | WO |
WO2014093148 | Jun 2014 | WO |
WO2015074018 | May 2015 | WO |
WO2015101747 | Jul 2015 | WO |
WO2015120146 | Aug 2015 | WO |
WO2015165736 | Nov 2015 | WO |
WO2017007853 | Jan 2017 | WO |
WO2017132247 | Aug 2017 | WO |
WO2017161166 | Sep 2017 | WO |
Entry |
---|
Aziz et al.; Chronic total occlusions—a stiff challege requiring a major breakthrough: is there light at the end of the tunnel?; Heart; vol. 91; suppl. III; pp. 42-48; Jun. 2005. |
Bayer Material Science: ; Snap-Fit Joints for Plastics; 26 pages; retrieved from the Internet: ( https://web.archive.org/web/20121119232733if_/http://fab.cba.mit.edu:80/classes/S62.12/people/vemnelle.noel/Plastic_Snap_fit_design.pdf) on Sep. 26, 2018. |
Choma et al.; Sensitivity advantage of swept source and fourier domain optical coherence tomography; Optics Express; 11(18); pp. 2183-2189; Sep. 8, 2003. |
De Boer et al.; Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography; Optics Letters; 28(21); pp. 2067-2069; Nov. 2003. |
Emkey et al.; Analysis and evaluation of graded-index fiber-lenses; Journal of Lightwave Technology; vol. LT-5; No. 9; pp. 1156-1164; Sep. 1987. |
Gonzalo et al.; Optical coherence tomography patterns of stent restenosis; Am. Heart J.; 158(2); pp. 284-293; Aug. 2009. |
Han et al.; In situ Frog Retina Imaging Using Common-Path OCT with a Gold-Coated Bare Fiber Probe; CFM6; San Jose, California; CLEO, May 4, 2008; 2 pages. |
Leitgeb et al.; Performance of fourier domain vs time domain optical coherence tomography; Optics Express; 11(8); pp. 889-894; Apr. 21, 2003. |
Linares et al.; Arbitrary single-mode coupling by tapered and nontapered grin fiber lenses; Applied Optics; vol. 29; No. 28; pp. 4003-4007; Oct. 1, 1990. |
Merriam Webster; Proximal (Definition); 10 pages; retrieved from the internet (https://www.merriam-webster.com/dictionary/proximal) on Jun. 9, 2021. |
Muller et al.; Time-gated infrared fourier-domain optical coherence tomography; CFM5; San Jose, California; CLEO May 4, 2008; 2 pages. |
Rollins et al.; Optimal interferometer designs for optical coherence tomography; Optics Letters; 24(21); pp. 1484-1486; Nov. 1999. |
Schmitt et al.; A new rotational thrombectomy catheter: System design and first clinical experiences; Cardiovascular and Interventional Radiology; Springer-Verlag; 22(6); pp. 504-509; Nov. 1, 1999. |
Sharma et al.; Common-path optical coherence tomography with side-viewing bare fiber probe for endoscopic optical coherence tomography; Rev. Sci. Instrum.; vol. 78; 113102; 5 pages: Nov. 6, 2007. |
Sharma et al.; Optical coherence tomography based on an all-fiber autocorrelator using probe-end reflection as reference; CWJ13; San Francisco, California; CLEO May 16, 2004; 4 pages. |
Shinkle et al.; Evaluation of stent placement and outcomes with optical coherence tomography; Interv. Cardiol.; 2(4); pp. 535-543; (manuscript version, 12 pages); Aug. 2010. |
Stamper et al.; Plaque characterization with optical coherence tomography. Journal of the American College of Cardiology. 47(8); pp. 69-79; Apr. 18, 2006. |
Suparno et al.; Light scattering with single-mode fiber collimators; Applied Optics; vol. 33; No. 30; pp. 7200-7205; Oct. 20, 1994. |
Tanaka et al.; Challenges on the frontier of intracoronary imaging: atherosclerotic plaque macrophage measurement by optical coherence tomography; Journal of Biomedical Optics; 15(1); pp. (011104-1)-(011104-8); Jan.-Feb. 2010. |
Wang et al.; Common-path endoscopic Fourier domain OCT with a reference Michelson interferometer; Proceedings of the SPIE; vol. 7566; pp. 75660L-75660L-7; Jan. 2010. |
Wikipedia; Hinge; 4 pages; retrieved from the internet (https://en.wikipedia.org/w/index.php?title=Hinge&oldid=479569345) on Jun. 9, 2021. |
Patel et al.; U.S. Appl. No. 17/816,673 entitled “Atherectomy catheter with serrated cutter,” filed Aug. 1, 2022. |
Number | Date | Country | |
---|---|---|---|
20230225616 A1 | Jul 2023 | US |
Number | Date | Country | |
---|---|---|---|
62191956 | Jul 2015 | US | |
62191986 | Jul 2015 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 17347419 | Jun 2021 | US |
Child | 18183432 | US | |
Parent | 16801047 | Feb 2020 | US |
Child | 17347419 | US | |
Parent | 15741928 | US | |
Child | 16801047 | US |